I have information and links for patients with viral hepatitis, and for those who care for them. I am very excited and have asked the FDA to speed up the approval of Pegasys.
Patients can now take their interferon once a week.
This combination is a big advance in HCV treatment. Effective treatments such as and high dose for hepatitis C and lamivudine for hepatitis B are now available, and the immediate future is bright for patients with viral hepatitis. Roche's which works better than regular interferons and only has to be taken once a week should be available this year. Pegasys will be marketed at a single 180 mcg dose while Schering's Pegintron is available in several doses. creating a compound that may be less toxic and very long acting. I add information to this web site weekly and want to make it the best resource I can for patients who are often told outdated or incorrect information.